fda glp-1 warning november 2025 Issues Warnings Against Illegal Marketing Beyond the Headlines: FDA Warning
Description
The difference is that compounding pharmacies mix the medication rather than it coming from the original manufacturer

SIBO (small intestinal bacterial overgrowth) is best resolved with enzyme blends that contain niche probiotics, as typical probiotics can actually feed the overgrowth and exacerbate SIBO symptoms

11,17,25 In addition, SGLT2i activate key regulatory pathways involving AMP-activated protein kinase (AMPK), sirtuin 1 (SIRT1), SIRT3, and peroxisome proliferator-activated receptor- coactivator 1 (PGC-1), leading to enhanced autophagic activity and suppression of inflammatory responses

Its weird, though, that my body will act like Im super low even though Im not

If you are taking warfarin (Coumadin), you will likely need more frequent INR blood tests when you first start a GLP-1 medication
